Glioma cells that have been stimulated with CCL5 show increased intracellular calcium levels and elevated Akt (p-Akt) and Ca2+/calmodulin-dependent protein kinase II phosphorylation (p-CaMKII) in a time- and dose-dependent manner. The gene discussed is CCL5; the disease is central nervous system cancer.